More Globe Newswire

View Older Stories View Newer Stories

Nov 7, 2025 09:21AM Thai vocational education representatives visit Guangxi Financial Vocational College, jointly discussing a new blueprint for vocational education
Nov 7, 2025 09:20AM GBank Financial Holdings Inc. and GBank Appoint Hilary R. Sledge-Sarnor as Executive Vice President, General Counsel, and Corporate Secretary
Nov 7, 2025 09:15AM Jet.AI and Consensus Core Complete Second Milestone of Canadian Hyperscale Data Center Project
Nov 7, 2025 09:15AM Edible Garden Schedules Third Quarter 2025 Financial Results and Business Update Conference Call
Nov 7, 2025 09:11AM Form 8.3 - IDOX plc - Octopus Investments
Nov 7, 2025 09:11AM Easy Environmental Solutions Begins Trading Under New Ticker Symbol “EZES”
Nov 7, 2025 09:06AM Just Published! A New Book that Promises Inspiration to Transform Lives with Love and Kindness: Kennedy's Inspiring Story
Nov 7, 2025 09:06AM Just Published! A New Book that Promises Inspiration to Transform Lives with Love and Kindness: Kennedy's Inspiring Story
Nov 7, 2025 09:05AM Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meet
Nov 7, 2025 09:05AM AB Amber Grid Operating Results for 9 months of 2025
Nov 7, 2025 09:04AM Lincoln Tech to Expand Presence in Texas with New Rowlett Campus
Nov 7, 2025 09:00AM Strategy Overview Named Champion of PitchIT Competition at IT Nation Connect 2025
Nov 7, 2025 09:00AM Werewolf Therapeutics Presents Data Expanding Its PREDATOR® Platform at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
Nov 7, 2025 09:00AM Changes in Nokia Corporation's own shares
Nov 7, 2025 09:00AM H/Advisors Abernathy Named Private Equity Wire’s U.S. PR & Communications Firm of the Year in 2025 for Second Consecutive Year
Nov 7, 2025 09:00AM ACCA Re-elects Three North American Members to the Global Accounting Body’s Council
Nov 7, 2025 09:00AM Bluum Unveils 17,000 Sq Ft Phoenix Facility
Nov 7, 2025 09:00AM RFN's SX-E60: A New Era of Control in Electric Off-Roading Explored at EICMA Roundtable
Nov 7, 2025 09:01AM Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
Nov 7, 2025 09:00AM Punchcut Appoints Akshat Srivastava Director of Design Engineering
Nov 7, 2025 09:00AM Legrand Acquires Avtron Power Solutions, a Global Provider of Load Banks & Power Quality Solutions
Nov 7, 2025 09:00AM IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Nov 7, 2025 09:00AM Trained Therapeutix Demonstrates RIDE-001 Trains Myeloid Cells for Anti-Tumor Immune Response in Preclinical Data Presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Nov 7, 2025 09:00AM Nurix Therapeutics Presents New Translational Data from First-in-Human Clinical Trial of Oral CBL-B Inhibitor NX-1607 Demonstrating Immune Activation and Tumor Microenvironment Remodeling
Nov 7, 2025 09:00AM Gold Prices Continue to Fluctuate at High Levels, Blue Hat's Gold Assets Deliver Significant Returns
Nov 7, 2025 09:00AM BioAtla’s Mecbotamab Vedotin (Mec-V), an AXL-targeting ADC, Demonstrates a Median Overall Survival (OS) of 21.5 months in Subtypes of Refractory Soft Tissue Sarcomas
Nov 7, 2025 09:00AM Wrap and LETAC Lead Policy Development for Human Centered Non-Lethal Integration of Humanoid Robotics in Public Safety
Nov 7, 2025 09:00AM BioAge Labs to Present at Jefferies Global Healthcare Conference in London
Nov 7, 2025 09:00AM Precision Optics Announces Product Development Agreement to Deliver Next-Generation Augmented Reality Sub-Systems for Fighter Pilots
Nov 7, 2025 09:00AM Nouscom Presents New Positive Phase 1/2b data of NOUS-209 at SITC 2025, Supporting Plans to Initiate Registration-Enabling Study for Cancer Interception in Lynch Syndrome Carriers
Nov 7, 2025 09:00AM Creative Realities Closes Acquisition of Cineplex Digital Media
Nov 7, 2025 09:00AM Trump Media Reports Third Quarter 2025 Results
Nov 7, 2025 09:00AM H/Advisors Abernathy Named Private Equity Wire’s U.S. PR & Communications Firm of the Year in 2025 for Second Consecutive Year
Nov 7, 2025 09:00AM Flare Therapeutics Presents Correlative Biomarker Analysis from the FX-909 Phase 1A Clinical Study at SITC 2025 40th Anniversary Annual Meeting
Nov 7, 2025 09:00AM Wearable Devices Expands into Asia’s Tech Powerhouse: Secures Exclusive Distribution Agreement in South Korea
Nov 7, 2025 09:00AM RFN's SX-E60: A New Era of Control in Electric Off-Roading Explored at EICMA Roundtable
Nov 7, 2025 09:00AM Draganfly to Host Shareholder Update Call on November 12, 2025
Nov 7, 2025 09:00AM Fullmark Energy Announces Completion of Redwood Projects Portfolio with Commercial Operations of 65MW San Jacinto Energy Storage Project
Nov 7, 2025 09:00AM NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program
Nov 7, 2025 09:00AM Coherus Oncology Presents at SITC Clinical Multiomic Biomarker Data for CHS-114, a Highly Selective anti-CCR8 Cytolytic Antibody
Nov 7, 2025 09:00AM MiNK Therapeutics Reports Durable Responses and Immune Reactivation with Allo-iNKT Cell Therapy agenT-797 in PD-1–Refractory Solid Tumors at SITC 2025
Nov 7, 2025 09:00AM Legrand Acquires Avtron Power Solutions, a Global Provider of Load Banks & Power Quality Solutions
Nov 7, 2025 09:00AM ETC’s Commercial/Industrial Unit Awarded Contracts Totaling $9.1 Million
Nov 7, 2025 09:00AM Round Table Pizza Brings Legendary Flavor to Austin Area
Nov 7, 2025 09:00AM CTS Corporation Declares a Dividend and Share Repurchase Program
Nov 7, 2025 09:00AM Elicio Therapeutics Reports Robust, Cytolytic mKRAS-Specific T Cell Responses Across Diverse Patient HLA in Ongoing Phase 2 AMPLIFY-7P Trial of ELI-002 7P and New ELI-004 Preclinical Data at SITC
Nov 7, 2025 09:00AM NextNRG Reports Preliminary October 2025 Revenue Growth of 196% Year-Over-Year
Nov 7, 2025 09:00AM Gold Prices Continue to Fluctuate at High Levels, Blue Hat's Gold Assets Deliver Significant Returns
Nov 7, 2025 09:00AM EQ Appoints Nicholas Nichols as Executive Vice President of Mutual Funds
Nov 7, 2025 09:00AM T-knife Therapeutics Presents Preclinical Data on PRAME-Targeted TK-6302 Highlighting its Potential as a Promising, Category-leading Therapy at the Society for Immunotherapy of Cancer (SITC) Annual Me
View Newer Stories View Older Stories